Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1990-03-13
1990-12-25
Springer, David B.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
576171, A61K 3147, C07D21520
Patent
active
049803603
ABSTRACT:
Improvement in the treatment of malaria has been demonstrated with 5-arylalkoxy primaquine compounds of the formula ##STR1## wherein R.sub.2 represents H or methyl, R represents an alkylene group having from about 2 to about 12 carbon atoms, R' represents a substituted or non-substituted aryl moiety, such as phenyl and napthyl, and pharmaceutically acceptable salts thereof, wherein the salt forming acid may be organic or inorganic in nature. These primaquine related compounds are effective in malarial chemotherapy, by exerting plasmodicidal activity on malarial parasites present in both the blood and formed tissues of the mammalian host. The 5-arylalkoxy primaquine compounds of the invention are at least as effective in malarial treatment as the prior art 5-alkoxy primaquine compounds, but are not as toxic as the 5-alkoxy compounds at higher dosage ranges.
REFERENCES:
patent: 1938047 (1933-12-01), Schonhofer et al.
patent: 2477479 (1949-07-01), Elderfield et al.
patent: 3948920 (1976-04-01), Nabih
patent: 4167638 (1979-09-01), Chen et al.
patent: 4209519 (1980-06-01), Kinnamon
patent: 4431807 (1984-02-01), Strube et al.
patent: 4554279 (1985-11-01), Saggiomo et al.
Calspan Corporation
Springer David B.
LandOfFree
5-(phenylalkoxy)primaquine compounds and their use for treatment does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with 5-(phenylalkoxy)primaquine compounds and their use for treatment, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and 5-(phenylalkoxy)primaquine compounds and their use for treatment will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1162987